Last reviewed · How we verify
NCT03638856
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
NA trial testing Misoprostol 200Mcg Tab in Abnormal Uterine Bleeding in 17 participants. Completed in 30 December 2018.
30 December 2018
Quick facts
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 17 |
| Start date | 30 September 2018 |
| Primary completion | 30 December 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Misoprostol 200Mcg Tab — full drug profile →
Conditions studied
- Abnormal Uterine Bleeding — all drugs for Abnormal Uterine Bleeding →
- Chronic Pelvic Pain — all drugs for Chronic Pelvic Pain →
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Who can join
Adults 18 to 45, female only, with Abnormal Uterine Bleeding or Chronic Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03638856
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Misoprostol 200Mcg Tab
Trials testing the same drug.
- NCT04080349 — Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only · Phase 4 · unknown
- NCT03064568 — Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy · Phase 4 · completed
Other recruiting trials for Abnormal Uterine Bleeding
Currently open trials in the same condition.
- NCT07349108 — Comparison of Manual Vacuum Aspiration and Dilatation and Curettage for Endometrial Sampling Adequacy in Women With Abno · NA · active not recruiting
- NCT06653400 — Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy · Phase 1 · recruiting
- NCT07496905 — The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial · NA · recruiting
- NCT07169214 — Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding · Phase 1 · recruiting
- NCT07183501 — Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder · NA · recruiting
Other Department of Medical Services Ministry of Public Health of Thailand trials
Trials by the same sponsor.
- NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
- NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
- NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
- NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
- NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03638856 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
- Last refreshed: 22 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03638856.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing